Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: An analysis of 227 published cases

Clinical Neurology and Neurosurgery

Volumn 104, Issue 4, 2002, Pages 359-363

  Wirtz, Paul W ^a   Smallegange, Thierry M ^a   Wintzen, Axel R ^a   Verschuuren, Jan J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmunity; Lambert Eaton myasthenic syndrome; Muscle weakness; Myasthenia gravis; Paraneoplastic syndrome; Small cell lung carcinoma

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; AUTOIMMUNE DISEASE; CANCER DIAGNOSIS; CARCINOMA; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; FEMALE; HUMAN; IMMUNOPATHOLOGY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARANEOPLASTIC SYNDROME; PUBLISHING;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CARCINOMA; CHILD; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MIDDLE AGED; PROGNOSIS; SEX FACTORS;

EID: 0036319035     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(02)00054-9     Document Type: Article

References (12)

1. Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome
2. The role of autoantibodies in Lambert-Eaton myasthenic syndrome
3. The Lambert-Eaton myasthenic syndrome. A review of 50 cases
4. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line
5. The National Cancer data Base Report on Lung Cancer
6. Autoimmunity in the Lambert-Eaton myasthenic syndrome
7. Lambert-Eaton myasthenic syndrome: Electrodiagnostic findings and response to treatment
8. The course of myasthenia gravis and therapies affecting outcome
9. The association of autoimmune disorders with inflammatory bowel disease
10. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome
11. The Lambert-Eaton myasthenic syndrome: A study of 110 Japanese cases
12. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: Serologic and clinical correlates